ArticleBiomedicines2025

The IL-6/JAK/STAT3 Axis in Cholangiocarcinoma and Primary Sclerosing Cholangitis: Unlocking Therapeutic Strategies Through Patient-Derived Organoids.

Corinna Boden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.